secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2025-11-19T23:59:59+00:00
Accession:  0000885725-25-000052
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific approves 2026 annual bonus and performance share programs with similar structure to 2025
--------------------------------------------------------------------------------

- 2026 Annual Bonus Plan approved; bonus pool 0%-150% of target based on global sales, adjusted EPS, operating income, and sustainability goals.
- 2026 rTSR PSP measures TSR vs S&P 500 Healthcare Index over 3 years (2026-2028); awards 0%-200% of target.
- 2026 Organic Net Sales PSP measures organic net sales growth vs financial plan over 3 years; awards 0%-200% of target.
- Both performance programs forfeit if retirement before Jan 1, 2027; all awards subject to clawback policies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572525000052/0000885725-25-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572525000052/bsx-20251118.htm
  HTML page:      https://secwatch.observer/filing/0000885725-25-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer